Intravenous Lidocaine for Perioperative and Postoperative Analgesia

• Status: Unknown status
• Trial end date: 2020-01-30
• Target enrollment: 0
• Participant gender: All

Summary

Postoperative pain continues to be untreated despite the application of multimodal analgesia, medication and new analgesic techniques. Traditional opioid pain treatment has many side effects, while invasive methods, such as epidural catheter, have high costs and difficulties during application.

Lidocaine is a local anesthetic and its administration with intravenous routes has analgesic, antihyperalgic and antiinflammatory action. It increases the motility of the intestine and has antiemetic properties. The advantage of this method is the low cost of the preparation and its easy application. The intravenous administration of lidocaine for postoperative analgesia is recently used and not sufficiently researched technique .

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rajmonda Nallbani-Komoni
• Treatments: Anesthetics; Anti-Inflammatory Agents; Ketamine; Lidocaine

Criteria

Inclusion Criteria:

• Age of both genders from 18 to 75 years

• ASA physiological status I-III

• Participation in abdominal, orthopedic, laparoscopical, gynecological and urological interventions.

Exclusion Criteria:

• Patient rejection

• History of chronic opioid intake

• History of renal, hepatic or psychiatric disorders

• Heart failure,

• Organ transplant history,

• Lidocaine allergy

• Family history of malignant hyperthermia